NCT01883960

Brief Summary

The primary goal of this study is to establish and evaluate an image-based biomarker for the impaired motor control and sensory information processing present in Cerebral palsy (CP) and stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

June 10, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 21, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

February 11, 2015

Status Verified

June 1, 2011

Enrollment Period

4 years

First QC Date

June 10, 2013

Last Update Submit

February 10, 2015

Conditions

Keywords

cerebral palsycerebral vascular accidentmulti-modal brain techniquesMRImotor control

Outcome Measures

Primary Outcomes (1)

  • Change from baseline of fMRI analysis in 6 months and 12 months

    fcMRI at resting, active-task fMRI. DTI

    baseline, 6 months, 12 months

Secondary Outcomes (8)

  • Change from baseline of Quality of life in 6 months and 12 months

    baseline, 6 months, 12 months

  • Change from baseline of movement and participation for Healthy adults and stroke patients in 6 months and 12 months

    baseline, 6 months, 12 months

  • Change from baseline of movement and participation for stroke patients in 6 months and 12 months

    baseline, 6 months, 12 months

  • Change from baseline of movement and participation for Healthy children and CP in 6 months and 12 months

    baseline, 6 months, 12 months

  • Change from baseline of movement and participation for CP in 6 months and 12 months

    baseline, 6 months, 12 months

  • +3 more secondary outcomes

Study Arms (4)

healthy adults

Inclusion criteria for healthy adults were as follows: 40-70 y/o; good cognition and cooperation; and healthy adults.

stroke subjects

Inclusion criteria for subjects with brain damage by stroke were as follows: a diagnosis of first-time-onset stroke and aged 40-70 years old.

CP subjects

Inclusion criteria for subjects with brain damage by CP were as follows: a diagnosis of CP and aged 16-18 years old.

healthy children

Inclusion criteria for healthy children were as follows: ages of 6-18 y/o ; good cognition and cooperation; and healthy children.

Eligibility Criteria

Age6 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

CP and CVA, and healthy children, and adults

You may qualify if:

  • CP-patients with CP and aged 6-18 years
  • CVA-patients with stroke and aged 40-75 years

You may not qualify if:

  • contraindication to MRI
  • history of psychiatric disease
  • received BTX-A injection or surgery in recent six months
  • severe psychological impairments, such as mental retardation, autism or severe communication problems
  • progressive disorders, such as neurodegenerative disease
  • active medical disease, such as infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

Location

MeSH Terms

Conditions

Cerebral PalsyStroke

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCerebrovascular DisordersVascular DiseasesCardiovascular Diseases

Study Officials

  • Chia-Ling Chen, PhD

    Department of Physical Medicine & Rehabilitation, Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2013

First Posted

June 21, 2013

Study Start

September 1, 2010

Primary Completion

September 1, 2014

Study Completion

December 1, 2014

Last Updated

February 11, 2015

Record last verified: 2011-06

Locations